Finanzwire Finanzwire
Basculer en Français
10656 Companies
226807 Keywords
155246 Articles
120075 Press releases
Headlines Articles Press releases Smart IMS Remove
  1. Home
  2. Companies
  3. Smart IMS
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/05/2024 at 23:30, 2 years 5 months ago

    Smart IMS Strengthens Executive Team, Insurtech Leader Anil Chitale Appointed as Managing Director

    Smart IMS, a leading technology service and solutions provider, has appointed Anil Chitale as the Managing Director. With over 35 years of experience in the U.S. Insurance industry, Anil's addition to the executive team is expected to further strengthen the company's offerings in the Insurance space. The company aims to leverage Anil's expertise to enhance its business growth and provide world-class technology solutions to its clients in the fast-changing technology and regulatory environment. Smart IMS is headquartered in Plainsboro, New Jersey and offers a wide range of global technology solutions including Application & Infrastructure Management services, Unified Communications, and Life Sciences and Insurance services.
    Smart IMS Technology Solutions Insurance Industry Anil Chitale Plainsboro New Jersey
    Logo of Smart IMS
Accesswire
  • Published on 06/29/2026 at 15:00, 2 hours 29 minutes ago

    Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah

  • Published on 06/29/2026 at 15:00, 2 hours 29 minutes ago

    Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement

  • Published on 06/29/2026 at 14:30, 2 hours 59 minutes ago

    Unusual Machines Added to Russell 2000(R) Index

  • Published on 06/29/2026 at 14:30, 2 hours 59 minutes ago

    Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web

  • Published on 06/29/2026 at 14:30, 2 hours 59 minutes ago

    US FDA Has Granted A "Rare Pediatric Disease Drug" Designation for NV-387 As A Treatment for Measles - Enables Priority Review Voucher

View all ACCESSWIRE
EQS Group
  • Published on 06/29/2026 at 16:48, 40 minutes ago

    Amprion successfully signs €6.5 billion “Energiewende Green Revolving Credit Facility”

  • Published on 06/29/2026 at 16:45, 43 minutes ago

    World's First Commercial Multimodal LLM for Cultural Tourism Enters Broad Application

  • Published on 06/29/2026 at 16:29, 59 minutes ago

    Aroundtown SA notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities

  • Published on 06/29/2026 at 16:29, 59 minutes ago

    Aroundtown SA notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities

  • Published on 06/29/2026 at 16:23, 1 hour 5 minutes ago

    Form 8.3 - Advanced Medical Solutions Group PLC

View all EQS
Les Echos
  • Published on 06/29/2026 at 16:39, 49 minutes ago

    Statement of transactions in own shares from June 22, 2026 to June 26, 2026

  • Published on 06/29/2026 at 16:30, 59 minutes ago

    Capital increase through exercise of subscription rights

  • Published on 06/29/2026 at 10:56, 6 hours 32 minutes ago

    GUILLEMOT CORPORATION S.A. | Weekly report share buyback from June 22 to June 26 2026

  • Published on 06/26/2026 at 17:45, 2 days 23 hours ago

    Combined General Meeting, June 25, 2026

  • Published on 06/26/2026 at 14:44, 3 days 2 hours ago

    Safran information

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy